Immunomodulator Management for COVID-19
Back to course
Video Transcription
Video Summary
Asset Subtitle
Immunology, Infection, 2022
Asset Caption
This session will cover the current understanding of COVID-19-related immune response, including moderate and severe disease, plus immune response to vaccination.
Meta Tag
Content Type Presentation
Knowledge Area Immunology
Knowledge Area Infection
Knowledge Level Advanced
Membership Level Select
Tag Infectious Diseases
Tag COVID-19
Year 2022
Keywords
immunomodulators
COVID-19
steroids
tocilizumab
baricitinib
patient outcomes

   

   
 
Society of Critical Care Medicine

500 Midway Drive
Mount Prospect, IL 60056 USA

Phone: +1 847 827-6888
Fax: +1 847 439-7226
Email: support@sccm.org


Contact Us

About SCCM

Newsroom

Advertising & Sponsorship

DONATE


MySCCM

LearnICU

Patients & Families

Surviving Sepsis Campaign

Critical Care Societies Collaborative


kisspng-facebook-social-media-computer-icons-linkedin-soci-gray-5ac493cf1c2975.7867418415228323351154  - KW Symphony    Gray twitter 3 icon - Free gray social icons    Gray linkedin 3 icon - Free gray site logo icons    Gray instagram icon - Free gray social icons    YouTube Icon Gray Box - HONOR VETERANS NOW

GET OUR NEWSLETTER






© Society of Critical Care Medicine. All rights reserved.   |    Privacy Statement    |    Terms & Conditions
The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.



Android App Download IOS App Download Powered By